Author | Number of cases | Modalities | Dose | Results | Major complications |
---|---|---|---|---|---|
Chang et al. (1999)[29] | 23 (P) | SRS | 7-15 Gy | 2-y LC 100% | no |
Tate et al. (1999)[30] | 23 (P) | SRS | 7-15 Gy | 2-y LC 100% | no |
Ahn et al. (2000)[31] | 19 (B) | FSRT | 8-40 Gy/4-20 f | 4-yr LC 89% | LMN 1 (5.3%) |
4-yr OS 75% | |||||
Xiao et al. (2001)[32] | 32 (P) | FSRT | 14-24 Gy/2-4 f | 3-y DFS 74% | FNH 2 (6%) |
3-yr OS 70% | |||||
Le et al. (2003)[19] | 45 (P) | SRS | 7-15 Gy | 3-y LC 100% | CNI 4 (8.9%) |
3-y OS 75% | TLN 3 (6.7%) | ||||
Chua et al. (2003)[33] | 7 (P) | SRS | 11-14 Gy | 2-y LC 100% | no |
Wu et al. (2007)[20] | 34 (P) | FSRT | 18 Gy/3 f | 3-y LC 89.4% | TLN 3 (8.8%) |
3-y DFS 80.7% | |||||
Hara et al.[33] (2008) | 82 (B) | SRS | 7-15 Gy | 5-y OS 69% | TLN 10 (12.2%) |
Present study | 136 (P) | FSRT | 8-32 Gy/2-8 f | 5-y DFS 73.6% | CNI 8 (5.9%) |
5-y OS 76.2% | TLN 6 (4.4%) | ||||
 |  |  |  |  | FNH 5 (3.7%) |